SCHEMBL17791095

SCHEMBL17791095

COc1cc(CO)ccc1Oc1cc(C(F)(F)F)ccc1C(=O)Nc1cccc(S(N)(=O)=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17791074 0.94 — —
SCHEMBL17791080 0.91 — —
SCHEMBL17791094 0.89 — —
SCHEMBL16398707 0.89 — —
SCHEMBL29918735 0.89 — —
SCHEMBL16408307 0.89 — —
SCHEMBL16408282 0.89 — —
SCHEMBL16408283 0.88 — —
SCHEMBL17791115 0.87 — —
SCHEMBL16398792 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160152561-A1 SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2016-06-02 — — US disclosed
Send feedback